An FDA Panel Just Voted to Widen Access to Peptides. Here’s What It Actually Means for the Longevity Space

Longevity Law Updates, Uncategorized

Article by: Tom Zuber and Carla Pareja Paris What Happened Last Week Last week at the FDA’s White Oak Campus, the agency’s Pharmacy Compounding Advisory Committee (PCAP) opened a two-day meeting to consider whether the seven popular peptides should be made easier to obtain through compounding pharmacies. The peptides on the agenda include BPC-157, KPV,…